➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Harvard Business School
Express Scripts
Colorcon
Merck

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Norethindrone - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for norethindrone and what is the scope of patent protection?

Norethindrone is the generic ingredient in twelve branded drugs marketed by Parke Davis, Mayne Pharma, Glenmark Generics, Aurobindo Pharma Ltd, Lupin Ltd, Janssen Pharms, Teva Branded Pharm, Accord Hlthcare, Amneal Pharms, Mylan Labs Ltd, Novast Labs, Duramed Res, and Barr, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for norethindrone. Twelve suppliers are listed for this compound. There are two tentative approvals for this compound.

Drug Prices for norethindrone

See drug prices for norethindrone

Drug Sales Revenue Trends for norethindrone

See drug sales revenues for norethindrone

Recent Clinical Trials for norethindrone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of VirginiaN/A
Ironwood Pharmaceuticals, Inc.Phase 1
Eisai Inc.Phase 1

See all norethindrone clinical trials

Generic filers with tentative approvals for NORETHINDRONE
Applicant Application No. Strength Dosage Form
  Start Trial  Start Trial1MG;0.01MG;75MGTABLET;ORAL
  Start Trial  Start Trial75MGTABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for norethindrone
Drug ClassProgestin
Medical Subject Heading (MeSH) Categories for norethindrone

US Patents and Regulatory Information for norethindrone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs NORETHINDRONE norethindrone TABLET;ORAL-28 202014-001 Sep 13, 2013 AB1 RX No No   Start Trial   Start Trial   Start Trial
Barr NORETHINDRONE ACETATE norethindrone acetate TABLET;ORAL 075951-001 May 25, 2001 AB RX No Yes   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd INCASSIA norethindrone TABLET;ORAL-28 207304-001 Sep 23, 2016 AB1 RX No No   Start Trial   Start Trial   Start Trial
Teva Branded Pharm NOR-QD norethindrone TABLET;ORAL-28 017060-001 Approved Prior to Jan 1, 1982 AB1 RX Yes Yes   Start Trial   Start Trial   Start Trial
Janssen Pharms MICRONOR norethindrone TABLET;ORAL-28 016954-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glenmark Generics NORETHINDRONE norethindrone TABLET;ORAL-28 091209-001 Jul 22, 2010 AB2 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKinsey
Harvard Business School
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.